Literature DB >> 30146016

Icariin alleviates murine lupus nephritis via inhibiting NF-κB activation pathway and NLRP3 inflammasome.

Bofeng Su1, Hong Ye2, Xiaohan You1, Haizhen Ni3, Xuduan Chen4, Linlin Li4.   

Abstract

AIMS: Lupus nephritis (LN) is a kidney inflammatory disease caused by systemic lupus erythematosus (SLE). Both NF-κB activation and NLRP3 inflammasome activation are implicated in LN pathogenesis, suggesting they are potential targets for LN treatment. Icariin, which is isolated from Chinese medicine Horny Goat Weed (Ying Yang Huo), has been shown to have anti-inflammation activity, and inhibit activations of both NF-κB and NLRP3 inflammasome. In present study, the effects of icariin on LN were evaluated in MRL/lpr mice. MAIN
METHODS: We treated MRL/lpr mice with icariin for 8 weeks and then analyzed the renal function and kidney pathology. We monitored the levels of anti-dsDNA antibody and the deposition of immune complex after icariin treatment. We also detected the macrophage infiltration, NF-κB activation, NLRP3 inflammasome activation and inflammatory cytokine TNF-α production in MRL/lpr mice after icariin treatment. KEY
FINDINGS: We found that MRL/lpr mice treated with icariin displayed significantly attenuated the renal disease. Icariin-treated mice showed significantly reduced serum anti-dsDNA antibody level and immune complex deposition. Icariin inhibited NF-κB activation and TNF-α production in MRL/lpr mice. Icariin inhibited CCL2 production and macrophage infiltration in MRL/lpr mice. Finally, icariin suppressed NLRP3 inflammasome activation and IL-1β production in MRL/lpr mice. SIGNIFICANCE: Icariin alleviated murine lupus nephritis via inhibiting NF-κB activation and NLRP3 inflammasome activation.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Icariin; Inflammasome; Lupus nephritis; Mice; NF-κB

Mesh:

Substances:

Year:  2018        PMID: 30146016     DOI: 10.1016/j.lfs.2018.07.009

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  12 in total

Review 1.  NOD-like receptors in autoimmune diseases.

Authors:  Li Chen; Shi-Qi Cao; Ze-Min Lin; Shi-Jun He; Jian-Ping Zuo
Journal:  Acta Pharmacol Sin       Date:  2021-02-15       Impact factor: 6.150

Review 2.  Current Concepts on the Reno-Protective Effects of Phosphodiesterase 5 Inhibitors in Acute Kidney Injury: Systematic Search and Review.

Authors:  Georgios Georgiadis; Ioannis-Erineos Zisis; Anca Oana Docea; Konstantinos Tsarouhas; Irene Fragkiadoulaki; Charalampos Mavridis; Markos Karavitakis; Stavros Stratakis; Kostas Stylianou; Christina Tsitsimpikou; Daniela Calina; Nikolaos Sofikitis; Aristidis Tsatsakis; Charalampos Mamoulakis
Journal:  J Clin Med       Date:  2020-04-29       Impact factor: 4.241

3.  Potential Molecular Mechanisms of Zhibai Dihuang Wan in Systemic Lupus Erythematosus Based on Network Biology.

Authors:  Zi Yang; Rui-Fei Xie; Min-Hong Zhong; Guan-Qun Xie; Yong-Sheng Fan; Ting Zhao
Journal:  Evid Based Complement Alternat Med       Date:  2020-04-13       Impact factor: 2.629

Review 4.  Mechanisms and Efficacy of Chinese Herbal Medicines in Chronic Kidney Disease.

Authors:  Mingming Zhao; Yi Yu; Rumeng Wang; Meiying Chang; Sijia Ma; Hua Qu; Yu Zhang
Journal:  Front Pharmacol       Date:  2021-03-29       Impact factor: 5.810

Review 5.  NLRP3 Inflammasome: Checkpoint Connecting Innate and Adaptive Immunity in Autoimmune Diseases.

Authors:  Yiwen Zhang; Wenlin Yang; Wangen Li; Yunjuan Zhao
Journal:  Front Immunol       Date:  2021-10-11       Impact factor: 7.561

Review 6.  Novel insights into NOD-like receptors in renal diseases.

Authors:  Juan Jin; Tao-Jie Zhou; Gui-Ling Ren; Liang Cai; Xiao-Ming Meng
Journal:  Acta Pharmacol Sin       Date:  2022-04-01       Impact factor: 7.169

Review 7.  Flavonoids in Treatment of Chronic Kidney Disease.

Authors:  Yi-Ling Cao; Ji-Hong Lin; Hans-Peter Hammes; Chun Zhang
Journal:  Molecules       Date:  2022-04-06       Impact factor: 4.411

Review 8.  Development of Broad-Spectrum Antiviral Agents-Inspiration from Immunomodulatory Natural Products.

Authors:  Mengxun Zhang; Jiaqing Zhong; Yongai Xiong; Xun Song; Chenyang Li; Zhendan He
Journal:  Viruses       Date:  2021-06-28       Impact factor: 5.048

Review 9.  The Role of Melatonin on NLRP3 Inflammasome Activation in Diseases.

Authors:  Burak Ibrahim Arioz; Emre Tarakcioglu; Melis Olcum; Sermin Genc
Journal:  Antioxidants (Basel)       Date:  2021-06-24

10.  Association of nucleotide-binding oligomerization domain-like receptor family pyrin domain-containing protein 3 polymorphisms with systemic lupus erythematosus disease activity and biomarker levels: A case-control study in Chinese population.

Authors:  Zhenzhen Su; Qian Niu; Zhuochun Huang; Bin Yang; Junlong Zhang
Journal:  Medicine (Baltimore)       Date:  2020-08-28       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.